Yi-Shu Tu, PhD. Senior Principal Scientist, Insilico Medicine Taiwan Ltd.
-主題：How AI works in new drug designs
-摘要：In this talk, I will share my experience in an AI-based drug discovery company, as an alumnus of BEBI. During my study at BEBI, my research was focused on cheminformatics and computer-aided drug design (CADD), with collaboration among laboratories across different disciplines. At Insilico Medicine, the medicinal chemists, biologists, AI scientists and CADD scientists work together with pharmas and CROs, across the different sciences, industries, and the world. I will share how the predictive and generative AI models are applied and help the progression of the drug discovery industry, from target finding, molecule design, and clinical outcome prediction.
Dr. Yi-Shu Tu is currently a Senior Principal Scientist at Insilico Medicine Taiwan Limited. He obtained his doctoral degree from BEBI, NTU, in 2015. Before joining Insilico Medicine, he has experienced as a visiting scientist at National Center for Agricultural Utilization Research, USDA, and a postdoctoral researcher at National Taiwan University.